Key facts
- Cornerstone AI’s last known valuation is $35.0M.
- It has raised $10.7M; the latest was Seed Round ($5.0M) in Sep 2024.
- Notable investors include Acrew Capital, Arif Nathoo, HBM Genomics, Healthy Ventures, Initiate Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cornerstone AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Cornerstone AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cornerstone AI
Developer of an AI-based healthcare platform designed to analyze clinical data. The company's platform provides automatic identification and correction of errors, standardization of text fields, imputation of missing data, and harmonization of clinical datasets, enabling biopharma firms to use more of their data faster and arrive at more precise analyses.
- Sector
- Healthcare
- HQ
- San Mateo, CA, United States
- Founded
- 2020
- Employees
- 18
- Website
- cornerstone.ai/
- Ownership
- Privately Held (backing)
Cornerstone AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cornerstone AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cornerstone AI in its N-PORT filings yet. We sweep new filings monthly.